Erratum: The top prescription drugs of 2009-2012 (ACS Chemical Neuroscience (2010) 2:6 (276-277) DOI:10.1021/cn200050c);The top prescription drugs of 2010 in the United States: Antipsychotics show strong growth

ACS Chemical Neuroscience

Volumn 2, Issue 6, 2011, Pages 276-277

  Lindsley, Craig W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ARIPIPRAZOLE; ATORVASTATIN; CLOPIDOGREL; DULOXETINE; ESCITALOPRAM; ESOMEPRAZOLE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; NEUROLEPTIC AGENT; OLANZAPINE; OXYCODONE; PIOGLITAZONE; PRESCRIPTION DRUG; QUETIAPINE; RECOMBINANT ERYTHROPOIETIN; ROSUVASTATIN;

CHRONIC DISEASE; DRUG INDUSTRY; EDITORIAL; HUMAN; MEDICAL INFORMATICS; PRIORITY JOURNAL; UNITED STATES;

EID: 79959198112     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400178w     Document Type: Erratum

References (4)

1. IMS Institute for Healthcare Informatics. See www.imshealth.com.
2. Bartholow, M. (2011) Top Prescription drugs of 2010. Pharmacy Times, May 2011 (www. pharmacytimes.com/publications/issue/2011/May2011/Top-200-Drugs-of- 2010).
3. Bartholow, M. (2010) Top Prescription drugs of 2009. Pharmacy Times, May 2010 (www. pharmacytimes.com/publications/issue/2010/May2010/Top-200-Drugs-of- 2009).
4. Lindsley, C. W. (2010) The Top Prescription Drugs of 2009 in the US: CNS Therapeutics Rank among Highest Grossing ACS Chem. Neurosci. 1, 407-408